Increased tumor-infiltrating CD8+Foxp3+ T lymphocytes are associated with tumor progression in human gastric cancer

[1]  M. Cai,et al.  Decreased expression of Beclin 1 correlates with a metastatic phenotypic feature and adverse prognosis of gastric carcinomas , 2012, Journal of surgical oncology.

[2]  Ying-chao Wang,et al.  Constitutive activation of STAT3 is predictive of poor prognosis in human gastric cancer , 2012, Journal of Molecular Medicine.

[3]  Jiang Li,et al.  Distribution, characterization, and induction of CD8+ regulatory T cells and IL-17-producing CD8+ T cells in nasopharyngeal carcinoma , 2011, Journal of Translational Medicine.

[4]  R. Geffers,et al.  Generation and function of immunosuppressive human and murine CD8+ T cells by transforming growth factor‐β and retinoic acid , 2011, Immunology.

[5]  M. Goldman,et al.  Expansion of regulatory CD8+CD25+ T cells after neonatal alloimmunization , 2011, Clinical and experimental immunology.

[6]  K. Lahl,et al.  CD8+Foxp3+ T cells share developmental and phenotypic features with classical CD4+Foxp3+ regulatory T cells but lack potent suppressive activity , 2011, European journal of immunology.

[7]  Lian Li,et al.  Association of Intra-tumoral Infiltrating Macrophages and Regulatory T Cells Is an Independent Prognostic Factor in Gastric Cancer after Radical Resection , 2011, Annals of Surgical Oncology.

[8]  D. Campbell,et al.  Phenotypical and functional specialization of FOXP3+ regulatory T cells , 2011, Nature Reviews Immunology.

[9]  A. Nowak,et al.  Harnessing the immune response to treat cancer , 2010, Oncogene.

[10]  J. Hong,et al.  Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells , 2010, Archives of pharmacal research.

[11]  H. Pircher,et al.  Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma. , 2010, Cancer research.

[12]  C. Loddenkemper,et al.  Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma. , 2010, Cancer research.

[13]  S. Sakaguchi,et al.  Regulatory T cells in tumor immunity , 2010, International journal of cancer.

[14]  W. Urba,et al.  CD122+CD8+ Treg suppress vaccine‐induced antitumor immune responses in lymphodepleted mice , 2010, European journal of immunology.

[15]  C. Zhong,et al.  Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer , 2010, Journal of Cancer Research and Clinical Oncology.

[16]  Dakang Xu,et al.  Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. , 2010, Clinical immunology.

[17]  H. Weiner,et al.  Novel CD8+ Treg suppress EAE by TGF‐β‐ and IFN‐γ‐dependent mechanisms , 2009, European journal of immunology.

[18]  R. Ramsey‐Goldman,et al.  Regulatory T Cell (Treg) Subsets Return in Patients with Refractory Lupus following Stem Cell Transplantation, and TGF-β-Producing CD8+ Treg Cells Are Associated with Immunological Remission of Lupus1 , 2009, The Journal of Immunology.

[19]  Dakang Xu,et al.  CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression. , 2009, Clinical immunology.

[20]  C. Akdis,et al.  Unique Phenotype of Human Tonsillar and In Vitro-Induced FOXP3+CD8+ T Cells1 , 2009, The Journal of Immunology.

[21]  N. Chaput,et al.  Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue , 2008, Gut.

[22]  R. Thimme,et al.  CD8+ regulatory T cells in persistent human viral infections. , 2008, Human immunology.

[23]  Rong-Fu Wang.  CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer. , 2008, Human immunology.

[24]  S. Chae,et al.  Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer , 2008, British Journal of Cancer.

[25]  H. Fujii,et al.  CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer , 2008, International journal of cancer.

[26]  K. Isobe,et al.  Essential Role of CD8+CD122+ Regulatory T Cells in the Recovery from Experimental Autoimmune Encephalomyelitis1 , 2008, The Journal of Immunology.

[27]  Lloyd J. Old,et al.  CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer , 2007, Clinical Cancer Research.

[28]  D. Olive,et al.  CD8+CD28− T Regulatory Lymphocytes Inhibiting T Cell Proliferative and Cytotoxic Functions Infiltrate Human Cancers1 , 2007, The Journal of Immunology.

[29]  T. Ottenhoff,et al.  Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4 , 2007, Proceedings of the National Academy of Sciences.

[30]  V. Reuter,et al.  CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma , 2007, Proceedings of the National Academy of Sciences.

[31]  Ximing J. Yang,et al.  Tumor Evasion of the Immune System by Converting CD4+CD25− T Cells into CD4+CD25+ T Regulatory Cells: Role of Tumor-Derived TGF-β , 2007, The Journal of Immunology.

[32]  A. Banham,et al.  Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma. , 2006, Clinical immunology.

[33]  J. V. van Meerwijk,et al.  CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. , 2006, Gastroenterology.

[34]  Z. Trajanoski,et al.  Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.

[35]  A. La Cava,et al.  Tolerogenic Treatment of Lupus Mice with Consensus Peptide Induces Foxp3-Expressing, Apoptosis-Resistant, TGFβ-Secreting CD8+ T Cell Suppressors1 , 2005, The Journal of Immunology.

[36]  T. Curiel,et al.  Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. , 2005, Cancer research.

[37]  Y. Kang,et al.  Cell-Based Immunotherapy with Suppressor CD8+ T Cells in Rheumatoid Arthritis1 , 2005, The Journal of Immunology.

[38]  Weiping Zou,et al.  Immunosuppressive networks in the tumour environment and their therapeutic relevance , 2005, Nature Reviews Cancer.

[39]  George Coukos,et al.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.

[40]  L. Cosmi,et al.  Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. , 2003, Blood.

[41]  G. Filaci,et al.  Impairment of CD8+ T Suppressor Cell Function in Patients with Active Systemic Lupus Erythematosus1 , 2001, The Journal of Immunology.

[42]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[43]  R. Ramsey‐Goldman,et al.  Regulatory T Cell (Treg) Subsets Return in Patients with Refractory Lupus following Stem Cell Transplantation, and TGF- -Producing CD8 Treg Cells Are Associated with Immunological Remission of Lupus , 2009 .

[44]  M. Pillinger.  Cell-based Immunotherapy With Suppressor CD8+ T Cells in Rheumatoid ArthritisDavila E, Kang YM, Park YW, et al (Emory Univ, Atlanta, Ga) J Immunol 174:7292–7301, 2005§ , 2006 .

[45]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.